InsidersTradesSigma
DXVX Stock: price and insider trades · South Korea · DART (FSS)
Track the DXVX stock price and the full insider trade history of the company, a listed issuer based in South Korea. Shares trade on KR KR, under the oversight of DART (FSS). Operating in the Health Care sector, DXVX has published 141 insider filings. Market capitalisation: €243.1bn. The latest transaction was reported on 26 June 2026 (Other). Among the most active insiders: 강현웅. Every trade is accessible without an account.
141
Insider Decl.
0
Thresholds
€1m
40 ops.
Buy Volume
·
19 ops.
Sell Volume
32Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 24,942 of 25,837 companies
13.2
score / 100
Value16
Quality10
FCF yld-8.4%
Earn yld-12%
EV/EBITDA·
ROE-9.6%
Gross mgn11%
Net mgn-99%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 26 June 2026
Declarations141 total
25 of 141 declarations
About DXVX
DXVX is a company operating in the healthcare and pharmaceutical sector, listed on the XKRX market.